Literature DB >> 3347702

Oxygen dependence of product formation in irradiated adenosine 5'-monophosphate.

A F Fuciarelli1, C J Koch, J A Raleigh.   

Abstract

The formation of (R)- and (S)-8,5'-cycloadenosine 5'-monophosphate (8,5'-cycloAMP), 8-hydroxyadenosine 5'-monophosphate (8-hydroxyAMP), and radiolytic adenine release from irradiated solutions of adenosine 5'-monophosphate (5'-AMP) was measured as a function of increasing liquid-phase oxygen concentration. Three classes of specific molecular damage were identified on the basis of the oxygen dependence for product formation. Major changes in product yield occurred near the range of oxygen concentrations associated with the radiobiological oxygen effect. In addition to these data, systematic increases in the concentration of hydrogen peroxide at the time of irradiation resulted in an increase in the yield of 8-hydroxyAMP and a component of radiolytic adenine release in nitrogen-saturated solutions of 5'-AMP. However, no changes in the yield of the 8,5'-cyclonucleotides were observed under these conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3347702

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  Structure and stability of duplex DNA containing (5'S)-5',8-cyclo-2'-deoxyadenosine: an oxidatively generated lesion repaired by NER.

Authors:  Tatiana Zaliznyak; Mark Lukin; Carlos de los Santos
Journal:  Chem Res Toxicol       Date:  2012-09-11       Impact factor: 3.739

2.  Theoretical analysis of DNA intrastrand cross linking by formation of 8,5'-cyclodeoxyadenosine.

Authors:  K Miaskiewicz; J H Miller; A F Fuciarelli
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

3.  Impact of breathing 100% oxygen on radiation-induced cognitive impairment.

Authors:  Kenneth T Wheeler; Valerie Payne; Ralph B D'Agostino; Matthew C Walb; Michael T Munley; Linda J Metheny-Barlow; Mike E Robbins
Journal:  Radiat Res       Date:  2014-10-22       Impact factor: 2.841

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.